WO2007117572A3 - Optical coherence tomographic detection of cells and killing of the same - Google Patents

Optical coherence tomographic detection of cells and killing of the same Download PDF

Info

Publication number
WO2007117572A3
WO2007117572A3 PCT/US2007/008536 US2007008536W WO2007117572A3 WO 2007117572 A3 WO2007117572 A3 WO 2007117572A3 US 2007008536 W US2007008536 W US 2007008536W WO 2007117572 A3 WO2007117572 A3 WO 2007117572A3
Authority
WO
WIPO (PCT)
Prior art keywords
cells
killing
optical coherence
same
coherence tomographic
Prior art date
Application number
PCT/US2007/008536
Other languages
French (fr)
Other versions
WO2007117572A2 (en
Inventor
Marc D Feldman
Thomas E Milner
Jihoon Kim
Jung-Hwan Oh
Pramod Sanghi
Jake Mancuso
Keith P Johnston
Leo Ma
Stanislav Emelianov
Original Assignee
Univ Texas
Marc D Feldman
Thomas E Milner
Jihoon Kim
Jung-Hwan Oh
Pramod Sanghi
Jake Mancuso
Keith P Johnston
Leo Ma
Stanislav Emelianov
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/441,824 external-priority patent/US7983737B2/en
Application filed by Univ Texas, Marc D Feldman, Thomas E Milner, Jihoon Kim, Jung-Hwan Oh, Pramod Sanghi, Jake Mancuso, Keith P Johnston, Leo Ma, Stanislav Emelianov filed Critical Univ Texas
Priority to CA002648691A priority Critical patent/CA2648691A1/en
Priority to EP07754968A priority patent/EP2010284A2/en
Priority to AU2007235395A priority patent/AU2007235395A1/en
Publication of WO2007117572A2 publication Critical patent/WO2007117572A2/en
Publication of WO2007117572A3 publication Critical patent/WO2007117572A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
    • A61B5/6847—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
    • A61B5/6852—Catheters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0062—Arrangements for scanning
    • A61B5/0066—Optical coherence imaging
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
    • A61B5/414—Evaluating particular organs or parts of the immune or lymphatic systems
    • A61B5/416—Evaluating particular organs or parts of the immune or lymphatic systems the spleen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/40—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals
    • A61N1/403—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals for thermotherapy, e.g. hyperthermia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/1717—Systems in which incident light is modified in accordance with the properties of the material investigated with a modulation of one or more physical properties of the sample during the optical investigation, e.g. electro-reflectance
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/47—Scattering, i.e. diffuse reflection
    • G01N21/4795—Scattering, i.e. diffuse reflection spatially resolved investigating of object in scattering medium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N2/00—Magnetotherapy
    • A61N2/02—Magnetotherapy using magnetic fields produced by coils, including single turn loops or electromagnets

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Surgery (AREA)
  • Immunology (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Vascular Medicine (AREA)
  • Optics & Photonics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)

Abstract

Provided herein are systems, methods and compositions for the use of optical coherence tomography for detection of cells and for killing detected cells.
PCT/US2007/008536 2005-05-27 2007-04-06 Optical coherence tomographic detection of cells and killing of the same WO2007117572A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CA002648691A CA2648691A1 (en) 2006-04-07 2007-04-06 Optical coherence tomographic detection of cells and killing of the same
EP07754968A EP2010284A2 (en) 2006-04-07 2007-04-06 Optical coherence tomographic detection of cells and killing of the same
AU2007235395A AU2007235395A1 (en) 2006-04-07 2007-04-06 Optical coherence tomographic detection of cells and killing of the same

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US68555905P 2005-05-27 2005-05-27
US79024806P 2006-04-07 2006-04-07
US60/790,248 2006-04-07
US11/441,824 2006-05-26
US11/441,824 US7983737B2 (en) 2005-05-27 2006-05-26 Optical coherence tomographic detection of cells and compositions

Publications (2)

Publication Number Publication Date
WO2007117572A2 WO2007117572A2 (en) 2007-10-18
WO2007117572A3 true WO2007117572A3 (en) 2008-08-21

Family

ID=56290939

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/008536 WO2007117572A2 (en) 2005-05-27 2007-04-06 Optical coherence tomographic detection of cells and killing of the same

Country Status (1)

Country Link
WO (1) WO2007117572A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7750536B2 (en) 2006-03-02 2010-07-06 Visualsonics Inc. High frequency ultrasonic transducer and matching layer comprising cyanoacrylate
EP2229147A2 (en) * 2007-12-03 2010-09-22 The Johns Hopkins University Methods of synthesis and use of chemospheres
WO2010111066A2 (en) 2009-03-23 2010-09-30 The General Hospital Corporation Innately multimodal nanoparticles
US10035009B2 (en) 2013-04-15 2018-07-31 The Board Of Trustees Of The Leland Stanford Junior University Systems and methods for treating pancreatic cancer
CA2942379C (en) 2014-03-12 2021-08-24 Fujifilm Sonosite, Inc. High frequency ultrasound transducer having an ultrasonic lens with integral central matching layer

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020193785A1 (en) * 1998-12-31 2002-12-19 Morteza Naghavi Method and apparatus for heating inflammed tissue
US20030055307A1 (en) * 2001-06-04 2003-03-20 David Elmaleh Devices for detection and therapy of atheromatous plaque
US20040254419A1 (en) * 2003-04-08 2004-12-16 Xingwu Wang Therapeutic assembly
US20050165298A1 (en) * 2003-09-04 2005-07-28 Crum, Kaminski & Larson, Llc Treatment of cardiac tissue following myocardial infarction utilizing high intensity focused ultrasound
US20050256207A1 (en) * 1997-10-27 2005-11-17 Mcgrath Michael Methods for modulating macrophage proliferation in ocular disease using polyamine analogs

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050256207A1 (en) * 1997-10-27 2005-11-17 Mcgrath Michael Methods for modulating macrophage proliferation in ocular disease using polyamine analogs
US20020193785A1 (en) * 1998-12-31 2002-12-19 Morteza Naghavi Method and apparatus for heating inflammed tissue
US20030055307A1 (en) * 2001-06-04 2003-03-20 David Elmaleh Devices for detection and therapy of atheromatous plaque
US20040254419A1 (en) * 2003-04-08 2004-12-16 Xingwu Wang Therapeutic assembly
US20050165298A1 (en) * 2003-09-04 2005-07-28 Crum, Kaminski & Larson, Llc Treatment of cardiac tissue following myocardial infarction utilizing high intensity focused ultrasound

Also Published As

Publication number Publication date
WO2007117572A2 (en) 2007-10-18

Similar Documents

Publication Publication Date Title
WO2006128167A3 (en) Optical coherence tomographic detection of cells and compositions
CL2007002017A1 (en) COMPOUNDS DERIVED FROM [4,5 '] - BIPIRIMIDINIL-6,4'-DIAMINE; PHARMACEUTICAL COMPOSITION; AND USE AS AN INHIBITOR OF THE ACTIVITY OF CINASA IN CANCER DE VEJIGA, CANCER CERVICAL AND MIELOMA MULTIPLE.
WO2008054676A3 (en) Medical devices and methods of using the same
WO2012054638A3 (en) Nmr systems and methods for the detection of analytes
EP2191227A4 (en) Forward-imaging optical coherence tomography (oct) systems and probe
EP1871219A4 (en) Methods and systems for physiological and psycho-physiological monitoring and uses thereof
WO2008100805A3 (en) Anti-robo4 antibodies and uses therefor
IL188050A (en) Azaindazole derivatives, pharmaceutical compositions containing the same and uses thereof
WO2007136893A3 (en) Anti-fgf19 antibodies and methods using same
EP1897882A4 (en) N2-quinolyl or isoquinolyl substituted purine derivatives, the preparation and uses thereof
EP4025257A4 (en) Antibody-drug conjugate comprising antibody against human ror1, and use for the same
WO2006124880A3 (en) Systems and methods to facilitate endoscopic interventions
GT200900014A (en) DERIVATIVES OF I - (- D-GLUCOPIRANOSIL) -3- (4-CYCLOPROPYLPENHYLMETHYL) -4-INDOLY HALOGEN USE OF THE SAME AS INHIBITORS OF THE SUCCUME DEPENDENT GLUCOSE CONVEYORS.
NL2000375A1 (en) Pyrimidine derivatives for the treatment of abnormal cell growth.
WO2008034013A3 (en) Medical devices and methods of making the same
WO2009042114A3 (en) Phenazine derivatives and uses thereof
WO2007013666A3 (en) Anti-tumor agents comprising r-spondins
NL1033063A1 (en) Tomographic imaging equipment and tomographic imaging method.
BRPI0815578A2 (en) CDCA1 PEPTIDE AND PHARMACEUTICAL AGENT UNDERSTANDING THE SAME.
WO2007081878A8 (en) Indoleamine 2,3-dioxygenase pathways in the generation of regulatory t cells
BRPI0818690A2 (en) Quinazolinedione derivatives, their preparation and their therapeutic uses.
WO2006138048A3 (en) Formulations comprising fluphenazine or derivatives thereof
BRPI0812766A2 (en) 4-CHLOR-4-ALCOXY-1,1,1-TRIFLUOR-2-BUTANONES, PREPARATION OF THE SAME AND USE OF THE SAME IN THE PREPARATION OF 4-ALCOXY-1,1,1-TRIFLUOR-3-BUTEN-2-ONAS
WO2008112903A3 (en) Genetic alterations on chromosome 16 and methods of use thereof for the diagnosis and treatment of type 1 diabetes
WO2007120156A3 (en) Animal models of long qt syndrome and uses thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07754968

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2648691

Country of ref document: CA

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2007235395

Country of ref document: AU

ENP Entry into the national phase

Ref document number: 2007235395

Country of ref document: AU

Date of ref document: 20070406

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2007754968

Country of ref document: EP